About Index Trending news
Analyze
Top 50 Pricing
Lexicon Pharmaceuticals

Lexicon Pharmaceuticals

Work at Lexicon Pharmaceuticals? Add yourself to this profile

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital
$4,662,780
Post-IPO equity
$130,000,000
Employees

Unknown size

Locations
HQ

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Lexicon Pharmaceuticals makes some noise.